The past 30 years have seen a huge change in the management and outcomes of patients with esophageal cancer. There has long been a perception of dismal outcomes for those… Click to show full abstract
The past 30 years have seen a huge change in the management and outcomes of patients with esophageal cancer. There has long been a perception of dismal outcomes for those patients requiring esophagectomy, with surgery associated with high levels of mortality, long-standing morbidity, and a prolonged hospital stay. Surgery has always been the cornerstone of curative treatment, allowing removal of the cancer. Lymphadenectomy has been a contentious component to surgery; some suggest that it confers no benefit but adds additional morbidity. There has been increased understanding of the need for lymphadenectomy and the importance of neoadjuvant treatment conferring optimal outcomes.
               
Click one of the above tabs to view related content.